Gadovist

DRUG5 trials

Sponsors

Aarhus University, Bracco Diagnostics, Inc, Guerbet, British Columbia Cancer Agency, Vanderbilt University Medical Center

Conditions

Brain LesionsMagnetic Resonance Imaging Contrast AgentsParotid NeoplasmsPeripheral Arterial DiseaseProgressive Fibrosing Interstitial Lung Diseases

Phase 2

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Active, not recruitingCTIS2022-502512-36-00

Aarhus UniversityProgressive Fibrosing Interstitial Lung Diseases

Start: 2023-10-02Target: 39Updated: 2025-01-31

Phase 4

Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

CompletedNCT00907530

Bracco Diagnostics, IncBrain Lesions

Start: 2009-09-30End: 2011-07-31Updated: 2012-01-05

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease

CompletedNCT01026389

GuerbetPeripheral Arterial Disease

Start: 2009-10-31End: 2012-01-31Updated: 2012-12-11

Unknown Phase

Feasibility Study of MRI Imaging on Parotid Gland Stimulation

British Columbia Cancer AgencyParotid Neoplasms

Start: 2014-12-31End: 2017-02-28Target: 10Updated: 2016-11-28

Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography

CompletedNCT03910114

Vanderbilt University Medical CenterMagnetic Resonance Imaging Contrast Agents

Start: 1990-07-01End: 2019-04-01Updated: 2019-04-10